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1. Introduction 
There are few long-term medical conditions and non-fatal injuries that are so inconvenient 
as the urinary incontinence in its various degrees. This situation effect the social life and 
there are consequences for the economic impact of this clinical condition in patients and 
health services. 
The direct costs associated with urinary incontinence is related to aspects such as diagnostic 
tests, doctor visits, surgery, use of diapers, and others. Among the indirect costs can include 
the time available for patients and friends to care of incontinent patients, and the loss of 
productivity for the individual hours away at work. The worsening quality of life of the 
patient is considered an intangible cost, difficult to measure in monetary terms, but which 
constitutes an integral aspect of urinary incontinence. 
Among the various causes of urinary incontinence, sphincter incompetence is one of the 
most common (Mundy, 1991). Fortunately, most patients with sphincter incompetence have 
simple stress incontinence, which usually responds well to one of several procedures for 
suspension of the bladder neck or urethra. However, surgery does not work without 
implants as favorably for the treatment of severe urinary sphincter, where the loss of 
urethral support is irrelevant (Mundy, 1991). In these circumstances, the best form of 
treatment is still the deployment of devices performing a specific function that compensates 
constrictor malfunction of the urethral sphincter (Hussain et al. 2005; Mundy, 1991; 
Schiavini et al. 2007; Vilar et al. , 2004). 
The initial treatment of urinary incontinence with urethral devices date from 1947, when 
Foley described the first artificial sphincter (Foley, 1947). According to its proposal, the 
penile urethra was exteriorized, involved with the foreskin and, after healing, the device 
was placed around the urethra. This device consisted of a tube connected to a syringe, the 
patient carried in his pocket, and when wanted to maintain continence, insert some fluid 
that would exert pressure through the syringe. Foley's method fell into disuse due to the 
high incidence of urethral injuries. 
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In 1973, Scott and colleagues, based on the idea of Foley, have created a toilet model totally 
implantable device, the AMS 721, which was modified and optimized by Rosen, 1976 
(Rosen, 1976, Scott et al., 1973). This device allowed compression of the bulbar urethra by 
inflating the device. Due to poor results, the device also fell into disuse. 
Changes were made in the initial design and the most important was the use of a balloon to 
regulate the pressure valve in place. 
Later models also incorporated an entirely new body of silicon, rather than a body of 
Dacron ®. A decrease in the number of components and connections resulted in the current 
AMS 800 (Fig. 01a), a device consisting of 3 parts (Hussain et al., 2005). 
The AMS 800 is a body-shaped strap that is placed around the bladder neck or bulbar 
urethra. This body is connected to a balloon pressure regulator via a control pump, located 
in the scrotum of the patient. The whole system is filled with saline, hydraulic operation. 
The pressure in the system and therefore the strength of the occlusive balloon body is 
determined by the throttle, being maintained in the system except when the pump is 
activated voluntarily by patients who do not account for intermittent catheterization. This 
activation provides the rapid emptying of saline in the body, which fluid is directed to the 
balloon pressure regulator, momentarily removing the occlusive force of the body and 
allowing urination by the patient (Fig. 01b). The body is kept empty for long enough (2-3 
min) so that urination is complete before returning to gain momentum due to the return of 
occlusive saline (Hussain et al. 2005; Mundy, 1991). 
Urinary incontinence after prostate surgery represents a social problem and public health, 
patient and burdening the state with direct and indirect costs and affect the quality of life of 
patients. The AMS 800 is the best treatment for the patients with severe sphincter 
incontinence, but preliminary data from the Constrictor Inflatable Periurethral are 
encouraging (Kuznetozov et al., 2000, Montague et al. 2001; Schiavini et al., 2007). 
Treatments such as collagen injections and the periurethral sling men do not appear as 
effective alternatives for long-term treatment of severe forms of this type of incontinence. 
Despite the long history of use, collagen injections are associated with success rates that 
generally do not exceed 40% cure rate. Due to the metabolism of collagen in the body, there 
is a gradual decrease in cure rates associated with the technique. This transient effectiveness 
usually takes the need for applying multiple injections on each patient, increasing the 
treatment without increasing the rates of long-term success (Carson, 2002, Cespedes et al., 
1999, Kuznetsov et al., 2000). 
The male sling appeared as a possible treatment for patients with sphincter incontinence 
after prostate surgery. However, the results were effective only in patients with mild to 
moderate incontinence (Castle et al., 2005). Sahaja & Terris, 2006, also pointed out that the 
male sling would not be as effective as a device with more physiological action, such as the 
artificial sphincter. For the structural similarity between the body of the AMS 800 and the 
Constrictor, this reasoning could be extended to the Constrictor.  
Another aspect to be considered is that, despite their recognized efficacy, the greater 
structural complexity of the AMS 800 has a direct impact on their high cost (Mundy, 1991). 
This is one of the reasons that explain the low access to this device for patients with urinary 
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sphincter in Latin America. Meanwhile, the Constrictor has provided preliminary efficacy 
results similar to the AMS 800, on a smaller device cost about 16 times. 
 
a) 
 
b) 
Fig. 1. a) AMS 800, a device of 3 parts - body, balloon and pump. b) Operating mode of the 
AMS 800 (Permission by American Medical Systems®) 
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2. Alternatives to the AMS 800 in the treatment of urinary incontinence 
Currently, the only device on the market, indicating the use and operational mode that 
resembles the AMS 800 in strengthening occluding the urethra is developed by Constrictor 
Inflatable Periurethral SILIMED (Rio de Janeiro – Brazil), a device consisting essentially of 2 
parts - body and valve constriction (Fig 2). 
 
Fig. 2. Periurethral constrictor SILIMED, a two-part device (constrictor cuff and self-sealing 
valve with tube) (Permission by SILIMED®). 
The main functional difference between the two devices is that the force of the occlusive 
body Constrictor Inflatable Periurethral remains constant throughout the duration of use of 
the device. If necessary, the patient's physician can make periodic adjustments of pressure in 
order to increase or decrease the force of the occlusive body, through the injection or 
removal of saline through the valve device in an outpatient setting. Meanwhile, the 
literature indicates a technical difficulty related to the change in pressure in the system of 
the AMS 800, possible only after revision surgery for the exchange of the balloon pressure 
regulator (Mundy, 1991). 
The medical and scientific literature presents both AMS 800 and the Constrictor Inflatable 
Periurethral (preliminary data) as trusted devices and with good durability. Any problems 
would be reversed, in most cases, for simple or surgical outpatient review, which would 
ensure good continence rates, according to the criteria of effectiveness adopted by different 
authors (Hussain et al. 2005; Mundy, 1991; Schiavini et al. , 2007; Vilar et al. 2004; Webster & 
Sherman, 2005). 
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The relative simplicity of the Constrictor apparently does not interfere with its effectiveness. 
Studies of the groups of Dr. Salvador Vilar and Dr. João Schiavini Constrictor present with 
continence rates of around 85% during treatment, as mentioned ahead. Moreover, the 
Constrictor was also able to provide some patients voiding spontaneously, especially in 
adults with urinary incontinence after prostate surgery sphincter. Even in cases where 
intermittent catheterization was used, the rate of patient satisfaction were generally high 
(Vilar et al. 2004; Schiavini et al., 2007). The main results are described ahead. 
2.1 Constrictor treatment in patients with neurogenic urinary incontinence 
In 2000, Lima and colleagues from the Hospital Infantil Manoel Almeida, Federal 
University of Pernambuco - Recife, presented results on the use of inflatable Periurethral 
Constrictor for the treatment of urinary incontinence secondary to myelomeningocele. The 
24 patients (14 men and 10 women) were in the age group 5 to 42 years, and were 
followed for an average of 4.2 years (1-84 months). Concomitant with the deployment of 
the device, 21 of these patients underwent cystoplasty to increase with the use of De-
epithelialize colon. Twenty-one patients had a good result with the device in addition to 
being functional continents, giving a success rate of 87.5%. In 3 (12.5%) cases, the device 
was removed due to the occurrence of erosion and infection. At the end of the study, the 
authors stated that the use of inflatable Periurethral Constrictor would be a safe and 
effective in the treatment of long-term causes of neurogenic urinary incontinence (Lima et 
al., 2000).  
In 2004, Vilar and colleagues presented a second study group related to the use of 
Constrictor Inflatable Periurethral the surgical treatment of urinary incontinence in 42 
children (29 boys and 13 girls) with a mean age of 10.2 years (3 to 17 years ). The group 
consisted of 29 neurogenic patients, 12 with bladder exstrophy and 1 with megalouretra. 
Concomitant with the deployment of the device, augmentation cystoplasty was performed 
in 34 patients. Patients were followed for an average of 5.2 years (4 to 104 months). In 25 
patients in the neurogenic group the device was functional and provided continence, which 
represented a rate of continent patients during treatment of 86%. In 4 (14%) patients, the 
device was removed due to erosion (3) and infection (1). The patient was continent and 
megalouretra urinated spontaneously. In the exstrophy group, 10 patients had their devices 
explanted due to erosion and incontinence. Only two kept the device and performed 
intermittent catheterization. The authors concluded that the Constrictor Periurethral would 
be a long-term alternative, safe and effective for the surgical treatment of urinary 
incontinence cause neurogenic sphincter in children. Like previously reported for other 
implants, the authors emphasized that the device should be used with caution in patients 
with bladder exstrophy (Vilar et al., 2004). 
2.2 Post-prostate surgery urinary incontinence.  
In 2007, Schiavini & Resende Jr and colleagues, University Hospital Pedro Ernesto, Rio de 
Janeiro, showed their initial experience with the use of inflatable Periurethral Constrictor. 
In this study, eighteen patients had urinary incontinence after radical retropubic 
prostatectomy, and five were previously submitted to procedures for the treatment of 
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bladder neck strictures. In all patients, the body of the device was placed around the bulbar 
urethra, with activation of the device after 8 weeks. Patients were followed from 6 to 36 
months. For the authors, successful treatment was predefined as the need to use a diaper 
until the day - social continence, together with patient satisfaction.  
2.2.1 Preoperative evaluation  
The complete urologic evaluation was performed, including urine analysis, ultrasonography, 
cystography and urodynamic studies before to submit the patients to the surgery, respecting 
the inclusion and exclusion criteria previously established, as described below. 
2.2.2 Inclusion criteria  
 Men;  
 18 years or more;  
 Diagnosis of sphincter incontinence after prostate surgery;  
 Be in good general health prior to participation in the study, no significant clinical 
abnormalities determined by: clinical history, physical examination, blood chemistry, 
blood count, urinalysis (the results of biochemical tests or hematology or urinalysis 
laboratory do not contain references, the patient may be included only if the researcher 
finds that the changes are not clinically significant);  
 Informed Consent in writing and signed by the patient.  
2.2.3 Exclusion criteria  
 Detrusor overactivity unresponsive to clinical treatment. 
 Low compliance bladder;  
 Use of drugs that interfere with bladder function;  
 Severe urethral stenosis,  
 History of significant disease (ex. cardiovascular, pulmonary, gastrointestinal, 
hematological, neurological, degenerative, hormonal, autoimmune or cancer).  
 History of psychological instability;  
 Presence of active infection; 
 Any situation that increases the possibility of infection / erosion after body contact 
device with the bulbar urethra (ex. sequelae of prior radiotherapy);  
 History of allergenicity to foreign bodies or silicone;  
 History of drug abuse in the last two years;  
 Risk that prevents surgical surgery / anesthesia;  
 Any condition, which in the opinion of the investigator, may interfere with the patient 
participation in the study (ex. difficulty of meeting the requirements of the study, attend 
appointments, or any other situation that may affect the response of the questionnaire 
on quality of life by the patient); 
 Patient expected to undergo surgery during the study period, which may affect the 
outcome;  
 Patient undergone previous surgical treatment for the treatment of sphincter 
incontinence.  
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Fig. 3. Urologic Evaluation 
2.3 Surgical approach and intra-operative procedures 
The patient is subjected to anesthesia in the operating room after evaluation by the 
anesthesiologist. Prophylaxis with intravenous antibiotics (3rd generation cephalosporin) 
will be held 30 minutes before starting surgery. Will be held genital shaving and antisepsis 
genital at least 5 minutes  and drapes are placed. 
www.intechopen.com
 
Urinary Incontinence 270 
Ureteroscopy with internal urethrotomy was performed when it was not possible to place a 
bladder catheter preoperatively. 
To implement the Constrictor Inflatable Periurethral around the bulbar urethra, the surgical 
access of up to 10cm in the perineal raphe, with the developer in the lithotomy position. The 
muscle fibers bulb-cavernous must be separated in the longitudinal direction, and the 
bulbar urethra dissected easily visible and later by creating the space for placing the 
constriction around her body (Fig-4). 
 
 
Fig. 4. Details of the constrictor cuff implantation around the bulbar urethra, after the 
dissection and separation of the bulbospongiosus muscle fibers. 
The pipe must be routed through the subcutaneous space and the valve implanted in the 
suprapubic region or subdartic within the scrotum, where it can be punctured (Fig-5). 
The Constrictor Inflatable Periurethral should have your air completely removed before 
being introduced into 2 ml of pyrogen-free saline. Meticulous haemostasis is essential to 
reduce risk of haematoma formation. 
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Fig. 5. Details of the valve implantation at the subdartic space of the scrotum. 
2.4 Post operative care  
The urethral catheter can be withdrawn on the 1st postoperative day. Activation of 
Inflatable Periurethral Constrictor should be held approximately 8 weeks (at least 6 and at 
most 12 weeks) after implantation, when a urodynamic study should be performed in 
conjunction with the measurement of pressure inside the device.  
To enable Inflatable Periurethral Constrictor, you should use a butterfly type intravenous 
scalp, 25G to 27G, previously filled with sterile saline, and pyrogen, to puncture the valve. 
The puncture should be done in the center of the constrictor valve in 90-degree angle, 
avoiding the edges of this valve, where the silicon is thinner, not to damage it. Must be 
injected sterile saline and pyrogen in an amount sufficient to produce continence, even 
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during sudden increase in abdominal pressure, such as episodes of coughing, but allows 
good urinary flow, without causing urinary retention.  
During the activation step, the clinician must be careful that the needle is inserted into the 
valve without excessive force, which could cause bending at the end of the needle and 
damage to the silicone septum during their re-treatment, thus undermining the proper 
functioning valve device.  
In addition, the use of large-caliber needles can destroy the valve. 
 
Fig. 6. Periurethral constrictor’s activation by injection of saline solution through the self-
sealing valve located at the scrotum. After activation, the patient had a good urine flow and 
achieved urinary continence. 
2.5 Efficacy variables 
The subjective and objective efficacy of the intervention was determined monthly in the first 
year and quarterly by the end of the third year (final visit) based on clinical results obtained 
in the patient Pad Test and questionnaires.  
The questionnaires validated quality of life WHOQOL (World Health Organization - 
Quality of Life) and ICIQ-SF (International Consultation on Incontinence Questionnaire - 
Short Form) were used as an instrument of measurement.  
www.intechopen.com
 
Treatment of Post-Prostatic Surgery Stress Urinary Incontinence 273 
2.6 Observations and measurements postoperative 
The recommendations for postoperative monitoring are in the figure below (Fig-7).  
 
 
Fig. 7. Urologic Evaluation Postoperative. 
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2.7 Results – AMS 800
®
 
Follow-up ranged from 27 to 132 months (mean 53.4 +- 21.4 months). There was a significant 
reduction in pad count from 4.0 +- 0.9 to 0.62 +- 1.07 diapers per day (P<0.001) leading to 
continence in 90%. Twenty patients (50%) were completely dry, and 16 (40%) required 1 pad 
per day. There was a significant reduction on the impact of incontinence decreasing from 5.0 
+- 0.7 to 1.4 +- 0.93 (P _0.001) in a visual analogue scale (VAS). Surgical revision rate was 
20%. Preoperative urodynamics was useful to identify sphincter deficiency. Except by a 
tendency of worse results in patients with reduced bladder compliance (RBC), other 
urodynamic parameters did not correlate with a worse surgical outcome. (Trigo Rocha F, et 
al. 2008). 
 
Fig. 8. Continence rates after AUS implantation in patients with PRPUI (Modified from 
Trigo Rocha F, et al. 2008) 
The main complications related to the AMS 800 are: Revision rate of the device in 5 years 
(26%), malfunctioning device (8%), pain/discomfort (6,9%), slow healing of wounds (5,7%), 
bladder spasms (2,3%), activation difficult (2,3%), displacement of the device (3,5%), erosion 
tissue (2,3%), disabling difficult (1,1%), infection (2,3%), recurring incontinence (3,5%), 
fistula formation (1,1%), hematoma (1,1%), swelling (2,3%), hydrocele (1,1%), erosion 
tissue/infection (1,1%), patient dissatisfaction (1,1%), incontinence position (1,1%), wound 
infection (1,1%), urinary retention (1,1%) (Shellock F, et al. 1988; Litwiller SE, et al. 1996) 
2.8 Results - Constrictor inflatable periurethral
®
 
The results obtained in 2007, four patients had neurogenic functional implants. Were 
continents and performed intermittent catheterization. In the group of prostatectomy 
patients, 15 had functional implants, and 2 performed intermittent catheterization. In three 
patients, the valve implant some leakage of saline, after activating the device, which was 
easily solved by changing the valves. Only one implant fail to function properly and was 
removed. Other two implants were removed early due to erosion, probably caused by 
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iatrogenic complications that occurred during dissection of the bulbar urethra. Thus, 19 
patients with functional implants represented a success rate of 86%, during an mean follow 
up of 28 months (6 to 50 months). (Schiavini et al, 2007).  
In the update made in 2010, and Schiavini & Resende Jr and colleagues, 30 patients were 
evaluated and followed up for a mean of 42.1 months (range, 13-72). In 22 patients (73.3%), 
the implanted devices were functional, 16 patients (53,3%) were completely dry, and 06 
(20%) required 1 pad per day; 20 voided spontaneously, and 2 performed intermittent 
catheterization. Among them, 7 patients were submitted for ambulatory review—within 2 
weeks of the activation of the device—to increase the occlusive static pressure of the cuff 
(range of volume added, 0.4-1.7 mL); and 4 were submitted for surgical exchange of the 
valve because of leakage of saline solution. Despite these occurrences, all of these patients 
claimed they were very satisfied with the results. 
The main complications were urethral cuff erosion in 4 patients (13.3%) and infection in 3 
patients (10%), leading in these cases to early and complete removal of the devices. An 
eighth patient remained incontinent after the device reactivation because of detrusor 
hyperreflexia. In this series, there was no occurrence of any other major complications. 
3. Comment and conclusion 
In the last years, the urological community has been developing new procedures to treat 
postprostatic surgery urinary incontinence. Despite their long history of use, collagen 
injections are associated with low cure rates. Moreover, collagen is gradually reabsorbed by 
the organism, leading to additional applications of the product, along with no significant 
increase in long-term cure (Cespedes.1999; Kuznetsov et al. 2000). 
The male sling appeared as another alternative treatment for these patients, but seems to be 
effective only in mild and moderate cases of postprostate surgery urinary incontinence  
(Castle et al. 2005; Montague et al. 2001). 
Although the artificial urinary sphincter is considered as the standard treatment for 
moderate and severe cases of postprostate surgery urinary incontinence, it is a high-cost 
device. In the present study, the authors present results of a surgical alternative for the 
treatment of postprostate surgery urinary incontinence. For this, we used the periurethral 
constrictor, a two-part device with a constrictor cuff positioned around the bulbar urethra 
and hydraulically activated through a self-sealing valve with a tube. Previous studies had 
already presented the device as a safe and effective alternative for the treatment of 
neurogenic urinary incontinence (Lima SVC, et al. 2000; Vilar FO, et al. 2004). 
This is particularly true if we consider that the erosion and infection cases were probably 
caused by bulbar urethral injuries that occurred during its dissection and cuff positioning in 
an early phase of the study during the learning curve of the technique. Along the series, 
there were no new cases of erosion and infection. 
Our experience indicates that the periurethral constrictor is less susceptible to mechanical 
problems or improper functioning, which agrees with the studies of neurogenic patients. 
The eventual problems were easily managed by simple surgical reviews with local 
anesthesia in the case of the exchange of leaking valves, or ambulatory reviews to adjust the 
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occlusive pressure of the system—once the presence of a self-sealing valve permits suitable 
readjustments through simple transcutaneal injections at any time on an outpatient basis, 
which makes the overall procedure safer and less expensive by avoiding unnecessary 
surgical reviews. In the case of the valves, we verified that the leakages were inadvertedly 
caused by needle perforations of the edge of the valve (where the silicone is thin) during the 
activation of the device. As a result of this, a project alteration of the valve that greatly 
diminished this risk was performed, and there was no occurrence of any other improper 
functioning of the device afterward. 
The periurethral constrictor may also be an important option in the treatment of sphincteric 
urinary incontinence in elderly, parkinsonian, and hemiplegic patients who have suffered 
cerebral vascular accident or other conditions that contribute to the decrease of manual 
dexterity (which would prevent the manipulation of the artificial sphincter’s mechanism). 
Another indication would be for incontinent patients who have sustained sphincter injury 
with bladder atony, which can benefit from the use of the device for staying dry and voiding 
by intermittent catheterization. 
Moreover, the low cost of the periurethral constrictor is also an important characteristic in 
its favor when compared with the already established AMS 800. The rates of efficacy that are 
apparently similar between both devices and the constrictor’s lower cost may encourage its 
use in all cases of postprostate surgery urinary incontinence where economic aspects are an 
important variable to be considered, including those where the artificial sphincter may also 
be indicated but its high cost prevents its use. 
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